Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database

Title: Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database
Authors: Martin, Mickaël; Nguyen, Hoan-My; Beuvon, Clément; Bene, Johana; Palassin, Pascale; Atzenhoffer, Marina; Rouby, Franck; Sassier, Marion; Pérault-Pochat, Marie-Christine; Roblot, Pascal; Allouchery, Marion; Puyade, Mathieu
Contributors: Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ); Centre Régional de Pharmacovigilance du Nord-Pas de Calais, Centre Hospitalier Universitaire de Lille; Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; Service Hospitalo-Universitaire de Pharmaco-Toxicologie, Hospices Civils de Lyon; CRPV Marseille Provence Corse, service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Marseille, France; Département de Pharmacologie, Centre Hospitalier Universitaire de Caen; SAFT Poitiers; Société des accumulateurs fixes et de traction (SAFT)
Source: ISSN: 2072-6694.
Publisher Information: CCSD; MDPI
Publication Year: 2022
Collection: Hospices Civils de Lyon (HCL): HAL
Subject Terms: [SDV.CAN]Life Sciences [q-bio]/Cancer
Description: International audience ; Data on immune checkpoint inhibitor (ICI)-related cytopenias are scarce. The aim of the study was to further characterize grade ≥ 2 ICI-related cytopenias using the French pharmacovigilance database. Immune thrombocytopenia and autoimmune hemolytic anemia were the most frequently reported ICI-related cytopenias (50.7% and 25.3%, respectively). Nearly half were grade ≥ 4, and 4.4% of patients died from cytopenia-related complications. Using the French pharmacovigilance database, this study provides a comprehensive analysis of ICI-related cytopenias that are rare but potentially life-threatening adverse drug reactions. Early recognition and timely initiation of appropriate treatment are key in their management in clinical practice.
Document Type: article in journal/newspaper
Language: English
DOI: 10.3390/cancers14205030
Availability: https://hal.science/hal-05085751; https://hal.science/hal-05085751v1/document; https://hal.science/hal-05085751v1/file/Martin%20et%20al.%20-%202022%20-%20Immune%20Checkpoint%20Inhibitor-Related%20Cytopenias%20Ab.pdf; https://doi.org/10.3390/cancers14205030
Rights: https://creativecommons.org/licenses/by/4.0/ ; info:eu-repo/semantics/OpenAccess
Accession Number: edsbas.BD1DBEB2
Database: BASE